|
US2006263449A1
|
|
Herbal composition for treatment of arthritic disorders, skin inflammatory disorders and pain
|
|
TW200630487A
|
|
Novel method for screening for GPCR agonists and/or antagonists from herbs
|
|
US2007009965A1
|
|
Novel method for screening for GPCR agonists and/or antagonists from herbs
|
|
TW200618793A
|
|
Hydrolysable tannin as TNF-α antagonist
|
|
US2006106098A1
|
|
Andrographolide and its derivatives as TNF-alpha antagonists
|
|
US2006105967A1
|
|
Flavone derivatives as TNFalpha inhibitors or antagonists
|
|
US6855343B2
|
|
Method to ascertain the quality of herbs
|
|
CN1459631A
|
|
Novel method for determining herb medicine quality
|
|
TWI220673B
|
|
Matrix metalloproteinase and tumor necrosis factor inhibitors
|
|
US6884627B2
|
|
Method for ascertaining the quality of herbs
|
|
US6683060B2
|
|
Matrix metalloproteinase and tumor necrosis factor inhibitors
|
|
TWI232936B
|
|
Plastic carrier for fabricating Bio-chip
|
|
US6908678B2
|
|
Plastic slides for the fabrication of biochips
|
|
JP2002212080A
|
|
Adenosine as anti-thrombogenic medicine
|
|
CN1391105A
|
|
Chinese-herbal medicine chip
|
|
TWI226927B
|
|
Herbal chip
|
|
US6645719B2
|
|
Herbal chip
|
|
EP1265070A1
|
|
Chip exposing plant extracts on its surface
|
|
EP1205754A2
|
|
Method for screening plant extracts for active ingredients
|
|
TWI248818B
|
|
Novel method for the screening of extract of plant for active ingredients
|
